Literature DB >> 33533711

Long-Term Survival Following Sepsis.

Konrad Schmidt1, Jochen Gensichen, Carolin Fleischmann-Struzek, Viola Bahr, Christine Pausch, Yasser Sakr, Konrad Reinhart, Horst Christian Vollmar, Paul Thiel, André Scherag, Julia Gantner, Frank M Brunkhorst.   

Abstract

BACKGROUND: There have not yet been any prospective registry studies in Germany with active investigation of the long-term survival of patients with sepsis.
METHODS: The Jena Sepsis Registry (JSR) included all patients with a diagnosis of sepsis in the four intensive care units of Jena University Hospital from January 2011 to December 2015. Long-term survival 6-48 months after diagnosis was documented by asking the treating general practitioners. The survival times were studied with Kaplan-Meier estimators. Cox regressions were calculated to show associations between possible predictors and survival time.
RESULTS: 1975 patients with sepsis or septic shock were included. The mean time of observation was 730 days. For 96.4% of the queries to the general practitioners, information on long-term survival was available. Mortality in the intensive care unit was 34% (95% confidence interval [32; 37]), and in-hospital mortality was 45% [42; 47]. The overall mortality six months after diagnosis was 59% [57; 62], the overall mortality 48 months after diagnosis was 74% [72; 78]. Predictors of shorter survival were age, nosocomial origin of sepsis, diabetes, cerebrovascular disease, duration of stay in the intensive care unit, and renal replacement therapy.
CONCLUSION: The nearly 75% mortality four years after diagnosis indicates that changes are needed both in the acute treatment of patients with sepsis and in their multi-sector long-term care. The applicability of these findings may be limited by their having been obtained in a single center.

Entities:  

Year:  2020        PMID: 33533711     DOI: 10.3238/arztebl.2020.0775

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  5 in total

Review 1.  Blood Sugar Targets in Surgical Intensive Care—Management and Special Considerations in Patients With Diabetes

Authors:  Johannes Roth; Oliver Sommerfeld; Andreas L Birkenfeld; Christoph Sponholz; Ulrich A Müller; Christian von Loeffelholz
Journal:  Dtsch Arztebl Int       Date:  2021-09-17       Impact factor: 5.594

2.  Characteristics and outcomes of sepsis patients with and without COVID-19.

Authors:  Lars Heubner; Sara Hattenhauer; Andreas Güldner; Paul Leon Petrick; Martin Rößler; Jochen Schmitt; Ralph Schneider; Hanns Christoph Held; Jan Mehrholz; Ulf Bodechtel; Maximilian Ragaller; Thea Koch; Peter Markus Spieth
Journal:  J Infect Public Health       Date:  2022-05-16       Impact factor: 7.537

3.  [Methodological weaknesses and errors in the data extraction lead to a substantial underestimation of the mortality of sepsis and septic shock in Germany].

Authors:  Konrad Reinhart
Journal:  Anaesthesist       Date:  2021-07-19       Impact factor: 1.041

4.  [Sepsis-associated deaths in Germany: characteristics and regional variation].

Authors:  Carolin Fleischmann-Struzek; Norman Rose; Konrad Reinhart
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-11-08       Impact factor: 1.513

5.  Effects of evidence-based ICU care on long-term outcomes of patients with sepsis or septic shock (ILOSS): protocol for a multicentre prospective observational cohort study in Japan.

Authors:  Keibun Liu; Toru Kotani; Kensuke Nakamura; Takai Chihiro; Yasunari Morita; Kenzo Ishii; Kenji Fujizuka; Daisetsu Yasumura; Daisuke Taniguchi; Tomohiro Hamagami; Nobutake Shimojo; Masakazu Nitta; Takashi Hongo; Kazuki Akieda; Maeda Atsuo; Tadashi Kaneko; Yutaka Sakuda; Kohkichi Andoh; Akiyoshi Nagatomi; Yukiko Tanaka; Yuhei Irie; Hiroshi Kamijo; Manabu Hanazawa; Daisuke Kasugai; Matsuoka Ayaka; Kenji Oike; Alan Kawarai Lefor; Kunihiko Takahashi; Hajime Katsukawa; Takayuki Ogura
Journal:  BMJ Open       Date:  2022-03-28       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.